Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study

Lipoprotein(a) Catabolism Is Regulated by Proprotein Convertase Subtilisin/Kexin Type 9 through the Low Density Lipoprotein Receptor

(2015) Rocco Romagnuolo et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans

(2015) Nike Müller et al.   JOURNAL OF LIPID RESEARCH

Effect of Alirocumab, a Monoclonal Proprotein Convertase Subtilisin/Kexin 9 Antibody, on Lipoprotein(a) Concentrations (a Pooled Analysis of 150 mg Every Two Weeks Dosing from Phase 2 Trials)

(2014) Daniel Gaudet et al.   AMERICAN JOURNAL OF CARDIOLOGY

Lipoprotein(a): Fasting and nonfasting levels, inflammation, and cardiovascular risk

(2014) Anne Langsted et al.   ATHEROSCLEROSIS

Lipoprotein(a) in various conditions: To keep a sense of proportions

(2014) Florian Kronenberg   ATHEROSCLEROSIS

Lipoprotein(a)

(2014) Florian Kronenberg   CIRCULATION

Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk

(2013) Amit V. Khera et al.   CIRCULATION

Causes and consequences of lipoprotein(a) abnormalities in kidney disease

(2013) Florian Kronenberg   Clinical and Experimental Nephrology

Lipoprotein(a): resurrected by genetics

(2013) F. Kronenberg et al.   JOURNAL OF INTERNAL MEDICINE

Lipoprotein(a) for Risk Assessment in Patients With Established Coronary Artery Disease

(2013) Michelle L. O'Donoghue et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The mysterious lipoprotein(a) is still good for a surprise

(2013) Claudia Lamina et al.   Lancet Diabetes & Endocrinology

Lipoprotein(a) concentrations, isoform size, and risk of type 2 diabetes: a Mendelian randomisation study

(2013) Pia R Kamstrup et al.   Lancet Diabetes & Endocrinology

Wasting and Sudden Cardiac Death in Hemodialysis Patients: A Post Hoc Analysis of 4D (Die Deutsche Diabetes Dialyse Studie)

(2011) Christiane Drechsler et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Sudden Cardiac Death in Hemodialysis Patients: An In-Depth Review

(2011) Darren Green et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

(2011) Charles A. Herzog et al.   KIDNEY INTERNATIONAL

Lipoprotein(a) and Risk of Type 2 Diabetes

(2010) S. Mora et al.   CLINICAL CHEMISTRY

Lipoprotein(a) as a cardiovascular risk factor: current status

(2010) Børge G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Apolipoprotein(a) Isoforms and the Risk of Vascular Disease

(2010) Sebhat Erqou et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Atheroma Progression in Chronic Kidney Disease

(2009) C. Rigatto et al.   Clinical Journal of the American Society of Nephrology

Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality

(2009)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Lipoprotein (a) as a risk factor for silent cerebral infarction in hemodialysis patients

(2008) Naoya Fukunaga et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology

(2007) Debbie A. Lawlor et al.   STATISTICS IN MEDICINE